Skip to content
ChickenStockChickenStock
ResearchBBIO
Bridgebio Pharma logo

Bridgebio Pharma (BBIO) stock

NASDAQ

$76.80-0.72%(-0.56)

As of the Nov 17, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-26.46x

Net loss — not comparable

P/B

—

P/S

15.85x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 191.7% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 29, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

18 SEC filings
  • Apuli MaricelChief Accounting Officer · Oct 30, 2026Open-market sale2,000 shares · $146K
    Avg. price $72.85120,687 shares held after
  • Kumar NeilChief Executive Officer · Sep 17, 2026Open-market sale10,000 shares · $691K
    Avg. price $69.0847
    Show 2 price lots
    • 8,721 shares × $69.0136$602K
    • 1,279 shares × $69.5696$89K
  • Kumar NeilChief Executive Officer · Aug 19, 2026Open-market sale10,000 shares · $840K
    Avg. price $84.0257
    Show 3 price lots
    • 8,100 shares × $83.8588$679K
    • 1,800 shares × $84.6867$152K
    • 100 shares × $85.65$9K
  • Kumar NeilChief Executive Officer · Aug 18, 2026Open-market sale34,980 shares · $2.9M
    Avg. price $82.5327
    Show 4 price lots
    • 17,279 shares × $82.2104$1.4M
    • 14,602 shares × $82.9922$1.2M
    • 1,900 shares × $81.1494$154K
    • 1,199 shares × $83.7732$100K
  • Kumar NeilChief Executive Officer · Aug 16, 2026Shares withheld for taxes36,237 shares · $2.9M
    Avg. price $79.86278,307 shares held after
  • Trimarchi ThomasPresident and CFO · Aug 16, 2026Shares withheld for taxes22,781 shares · $1.8M
    Avg. price $79.86336,529 shares held after
  • Apuli MaricelChief Accounting Officer · Aug 16, 2026Shares withheld for taxes4,714 shares · $376K
    Avg. price $79.86122,687 shares held after
  • Kumar NeilChief Executive Officer · Aug 16, 2026Option exercise71,217 shares
    Show 4 price lots
    • 6,520 sharesValue not reported
    • 11,554 sharesValue not reported
    • 19,599 sharesValue not reported
    • 33,544 sharesValue not reported
  • Apuli MaricelChief Accounting Officer · Jul 30, 2026Open-market sale2,000 shares · $160K
    Avg. price $80.06127,401 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Bridgebio Pharma (BBIO) stock information

NASDAQ

Bridgebio Pharma (BBIO) is listed on NASDAQ. Its market capitalization is about $15B. On trailing-twelve-month earnings the P/E ratio is -26.46. These figures are computed in-house from official filings and are reference information only.

Bridgebio Pharma — frequently asked questions

What is the P/E ratio of Bridgebio Pharma (BBIO)?
On a trailing-twelve-month basis, BBIO trades at a P/E ratio of -26.46. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Bridgebio Pharma?
BBIO has a market capitalization of about $15B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.